Despite the reduction in the immunosuppressive PD-1/PD-L1 axis and MDSC populations observed in carcinogen induced Stat1-deficient mice, they still displayed significantly higher mortality and burden of dysplasia and neoplasia compared to Stat1 competent mice. The gene discussed is STAT1; the disease is dysplasia.